Covid infection | show

 01/18/2022

 LOOKAH

A recent study conducted at Oregon State University (OSU) found that two compounds found in abundance in living cannabis plants can be used to prevent the virus that causes Covid-19 from entering human cells.

The study, published Monday, January 10 in the peer-reviewed Journal of Natural Products, tested several plant extracts such as wild yam, hops, red clover and licorice for possible affinity for the Covid spike protein.

According to the results of the study, the compounds cannabidiolic acid, CBDA, and cannabigerolic acid, or CBGA, were able to bind to the spike protein of the SARS-Cov-2 virus. This spike uses the coronavirus to hijack human cells. By binding to this spike, the same spike protein that the Covid-19 vaccines and antibody therapy drugs use, these compounds block a crucial step in the virus’s process of infecting people.

However, before you get overly excited about lighting a joint or dabbing, the study also showed that the two compounds are unlikely to be consumed via any of the traditional methods and have this benefit.

The compounds would have to be harvested separately and then used to manufacture specific drugs.

Lead author Richard van Breemen of OSU said, “These cannabinoid acids are abundant in hemp and in many hemp extracts.”

These CBDA and CBGA compounds are not controlled substances like the active ingredient in marijuana, THC, and they have a good safety profile in humans. Research showed that these hemp acids are equally effective against variants of SARS-Cov-2.